LDS/Medical Tests/Macroprolactin, Serum

Macroprolactin, Serum

Macroprolactin is a high molecular mass complex of prolactin, most often bound by immunoglobulin. Macroprolactin has reduced bioactivity and when it accumulates in the plasma it can cause a false positive result in prolactin testing.

Prolactin (PRL) is a hormone secreted by the anterior pituitary gland. Its primary purpose is to stimulate and maintain lactation in nursing mothers. It is under inhibitory control by dopamine, which is secreted from the hypothalamus. PRL circulates in the blood in monomeric (23 kDa), dimeric (48-56 kDa), and polymeric (>100 kDa) forms. The monomeric form is the most common bioactive form. In response to thyrotropin-releasing hormone (TRH), it signals to the pituitary to release PRL. In normal physiological functioning, PRL concentrations in postpartum mothers rise within minutes of breast-feeding. The main function of prolactin is the stimulation of milk production.

Hyperprolactinemia is a condition of elevated serum PRL. A number of pathological states can exhibit hyperprolactinemia including: micro- or macro- prolactinomas (PRL secreting adenomas), primary hypothyroidism, chest wall trauma, hypothalamic etiologies, section compression of pituitary stalk (typically by tumors that do not secrete PRL), empty sella syndrome, and chronic renal failure.

There are certain classes of drugs that have shown to cause elevated PRL, including dopaminergic-blocking agents, dopamine-depleting agents, noncatecholamine-dependent agents, H2-receptor blocking agents, and tricyclic antidepressants. Hyperprolactinemia may also be caused by the presence of accumulated macroprolactin. Often these patients might have normal levels of prolactin and usually are asymptomatic. Accumulation of macroprolactin is a frequent cause of misdiagnosis, so it is encouraged for laboratories to adopt a mechanism for ruling out the presence of Macroprolactin in patients with suspected prolactinoma and other causes of hyperprolactinemia.

  • As an aid in diagnosis of hyperprolactinemia in prolactinoma
  • Rule out elevated prolactin levels caused by Macroplactin interference, particularly in asymptomatic patients with Hyperprolactinemia 
  • Secondary test to hyperprolactinemia caused by prolactinomas when pituitary imaging results are inconclusive

 

Negative for Macroplactin

  • Precipitated protein by PEG is <50% of the total prolactin
  • If total prolactin is elevated and macroprolactin is negative (precipitation is <50%) , other testing is recommended to diagnose hyperprolactinemia

Positive for Macroplactin

  • Precipitated protein by PEG is >50% of the total prolactin
  • If total prolactin levels are elevated and the macroprolactin precipitation is >50%, hyperprolactinemia is indicated

Unprecipitated prolactin can be re-assayed.

  • If the PRL level exceeds the upper end of the reference range, other causes of hyperprolactinemia should be further investigated
  • If the PRL level is within reference interval, patient most likely has normal PRL levels despite falsely elevated initial results in the clinical test
Population Reference Range
Male >18 years 4.0 – 15.2 ng/mL
Female >18 years 4.8 – 23.3 ng/mL
PEG Precipitation, Gel Filtration Chromatography, Electrochemiluminscent Immunoassay.

Serum (STT tube). .

Stability

  • Ambient: 8-10 hours
  • Refrigerated: 2-3 days

Note: Samples collected 3-4 hours after subject has awaken, because PRL increases during sleep and peaks early in the morning.
Stress, exercise, ingestion of protein cause moderate elevation of PRL. Specimen is to be collected after overnight fast and in resting state.
Due to episodic secretion of PRL, sampling at varied time intervals might be preferred.
Twelve (12) hours prior to blood test, do not take supplements containing biotin or vitamin B7.

Prolactin, Estradiol, Follicle Stimulating Hormone, hCG, Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate, Liver function tests, serum creatinine and BUN
1-3 days
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Clin Chem. 2003;49 (9):1434-1436. [PMID: 12928232]
  • Clinical and Developmental Immunology. 2012;167132. [PMID: 23304187]
  • Clin Endrocrinol. 2005;62: 633-643. [PMID: 15943822]
  • Endocrinol Metab Clin North Am. 1992 Dec;21(4):877-901. [PMID: 1486880]
  • J Mammary Gland Biol Neoplasia. 1997 Jan;2(1):59-68. [PMID: 10887520]
  • Tietz NW, Burtis CA, Ashwood ER, Bruns DE: Tietz Textbook of Clinical Chemistry and Molecular Diagnostics 2006; 4th Edition.